Numbing cream may take the sting out of pelvic pain injections
NCT ID NCT07778043
First seen Aug 21, 2026 · Last updated Sep 04, 2026 · Updated 2 times
Summary
This trial tests whether a numbing cream (lidocaine-prilocaine) can reduce pain during trigger point injections for pelvic floor muscle pain. Adults undergoing these in-office injections will receive either the numbing cream or a placebo cream before the procedure. The study measures pain during and right after the injection to see if the cream helps.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Lidocaine-prilocaine cream (a numbing cream applied to the vaginal area before the procedure)
- What this could lead to
- If effective, this numbing cream could offer a simple, low-cost way to ease pain during common in-office pelvic pain injections, improving patient comfort.
- What could go wrong
- This is a small pilot study, so results may not be definitive. The cream may not reduce pain more than placebo, and some people may have skin irritation or allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
About 36 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Jul 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients 18 years or older * Patients who are undergoing in-office levator muscle trigger point injection for myofascial pelvic pain * Able to give informed consent for the study Exclusion Criteria: * Documented allergy to lidocaine or prilocaine * Use of lidocaine or prilocaine within last 72 hours
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Myofacial pain are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- WorkoutCPP: a pilot series of N-of-1 trials evaluating RL-Generated adaptive exercise recommendations for pelvic pain management
- Could simple exercises restore pelvic health after cervical cancer?
- A shot of numbing relief: could trigger point injections cut opioid use after neck surgery?
- Building a biological treasure trove to decode Women's health mysteries
- Can watching videos before surgery calm nerves?
- Double nerve block may ease pain after keyhole surgery